Roche Diagnostics Investor Day 2021

Roche has hosted a virtual event on Tuesday, 23 March 2021.

Diagnostics market opportunities, strategy and organisation
Overview on R&D and new technologies
Late stage pipeline: Systems and diagnostics solutions for selected disease areas such as infectious diseases, cardiology and oncology

Please register to access the replay of the management presentations session 1*
Please register to access the replay of the management presentations session 2*
Please register here to access the virtual 360° platform

*Privacy notice

Additional Information

Investor updates

All

Published on: 13 April 2021

FDA Approves Xolair (omalizumab) Prefilled Syringe for Self-Injection Across All Indications

Published on: 12 April 2021

Phase III prevention trial showed subcutaneous administration of investigational antibody cocktail casirivimab and imdevimab reduced risk of symptomatic COVID-19 infections by 81%

Published on: 8 April 2021

New Roche data at 2021 AAN highlight impact and breadth of expanding neuroscience portfolio

IR events

All

21April

Roche 1st Quarter Sales 2021

(CEST)

Basel, CH

more add to calendar

13May

Bank of America 2021 Healthcare Conference (virtual event)

(PST)

Las Vegas, US

add to calendar

19May

Wolfe Research Pipelines Unplugged Series (virtual event)

(EDT)

New York, US

add to calendar

Share price

Latest annual report

Highlights Annual Report 2020

How medicines are making an impact in the lives of patients

Pipeline

Get up-to-date information about our pipeline.

Roche R&D

Genentech Biooncology

Diagnostics overview

Get an introduction to our Diagnostics business.

Diagnostics news

Sustainability

Sustainability download center

Sustainability at Roche

Non-financial reporting

Dividend calendar

Timetable for the payment of the 2020 dividend

Total return center

Investor tool providing analysis of total returns

FAQ

Get answers to frequently asked questions

Roche Diagnostics Investor Day 2021

Additional Information

Related links

Investor updates

FDA Approves Xolair (omalizumab) Prefilled Syringe for Self-Injection Across All Indications

Phase III prevention trial showed subcutaneous administration of investigational antibody cocktail casirivimab and imdevimab reduced risk of symptomatic COVID-19 infections by 81%

New Roche data at 2021 AAN highlight impact and breadth of expanding neuroscience portfolio

IR events

Roche 1st Quarter Sales 2021

Bank of America 2021 Healthcare Conference (virtual event)

Wolfe Research Pipelines Unplugged Series (virtual event)

Share price

Latest annual report

Highlights Annual Report 2020

Historic quarterly reporting

Finance information tool

Pipeline

Pipeline

Roche R&D

Genentech Biooncology

Diagnostics

Diagnostics overview

Sustainability

Sustainability download center

Sustainability at Roche

Non-financial reporting

Dividend and total return

Dividend calendar

Total return center

Frequently asked questions

FAQ

US investors

How to invest

Contact

For all general enquiries

For IR requests

For all general enquiries

For IR requests